Hydrocortisone/Ciprofloxacin

Hydrocortisone/Ciprofloxacin

DEA Class; Rx

Common Brand Names; Cipro HC Otic

  • Antibiotics/Corticosteroids, Otic

Fluoroquinolone/corticosteroid combination otic suspension for acute otitis externa due to Proteus mirabilis, Pseudomonas aeruginosa, and Staphylococcus aureus.

Indicated for the treatment of acute otitis externa due to susceptible organisms.

Hypersensitivity to drugs or components

Tympanic membrane perforation (nonsterile preparation)

Viral infections of external canal including varicella & herpes simplex infections

  • Headache
  • Pruritus
  • Migraine headache
  • Hyperesthesia
  • Paresthesias
  • Fungal dermatitis
  • Cough
  • Rash
  • Dermatitis
  • Urticaria
  • Alopecia

Not for ophthalmic use or injection

Prolonged use may result in bacterial or fungal overgrowth

Resistance to the product may develop

If infection not improved after one week of therapy, cultures should be obtained to guide further treatment

Discontinue at first appearance of skin rash or any other sign of hypersensitivity; serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following first dose, reported in patients receiving systemic quinolones; serious acute hypersensitivity reactions may require immediate emergency treatment

Dropper cap contains natural rubber (latex) which may cause severe allergic reactions

Pregnancy Category: C

Lactation: Excretion in breast milk unknown; not recommended

Adults

6 drops/day to affected ear(s).

Geriatric

6 drops/day to affected ear(s).

Adolescents

6 drops/day to affected ear(s).

Children

6 drops/day to affected ear(s).

Infants

Safety and efficacy have not been established.

Neonates

Safety and efficacy have not been established.

Ciprofloxacin hydrochloride/hydrocortisone

suspension

  • 0.2%/1%
DrugsAce
Logo